Ozempic vs Metformin: Key Differences for Weight Loss and Diabetes

Ozempic and metformin are two of the most commonly prescribed medications for type 2 diabetes, and both get attention for their weight loss effects. But comparing them head-to-head is a bit like comparing a sports car to a reliable sedan. One is flashier and more powerful, the other has been getting the job done quietly for decades at a fraction of the price.

:::takeaway

• Ozempic vs Metformin: Ozempic and metformin are two of the most commonly prescribed medications for type 2 diabetes, and both get attention for their weight loss effects.
• $4 to $30 at most pharmacies.
• Stimulates insulin release when blood sugar is elevated (not when it is normal, which reduces hypoglycemia risk).
• This has not been confirmed in humans, but Ozempic carries a boxed warning and is not recommended for people with a personal or family history of medullary thyroid carcinoma.

:::

Let me break down the real differences so you can have an informed conversation with your provider.

Ozempic vs Metformin at a Glance

How They Work: Two Completely Different Approaches

Understanding the mechanism of action helps explain why these medications produce such different results.

Metformin

Metformin has been the first-line treatment for type 2 diabetes since the 1990s. It works through three primary mechanisms:

1. Reduces glucose production in the liver. Your liver constantly releases stored glucose into your bloodstream. Metformin dials this down, which lowers fasting blood sugar levels.
2. Improves insulin sensitivity. Metformin helps your muscle and fat cells respond better to the insulin your body already produces.
3. Slightly reduces glucose absorption in the intestines. This has a modest effect on post-meal blood sugar spikes.

Metformin does not directly suppress appetite or slow digestion. Any weight loss from metformin is generally a secondary effect of better blood sugar control and slightly reduced calorie intake.

Ozempic

Ozempic contains semaglutide, a GLP-1 receptor agonist. It mimics the hormone GLP-1, which your body naturally produces after eating. Its effects include:

1. Stimulates insulin release when blood sugar is elevated (not when it is normal, which reduces hypoglycemia risk).
2. Suppresses glucagon secretion, which reduces liver glucose output.
3. Slows gastric emptying, meaning food stays in your stomach longer and you feel full sooner.
4. Acts on appetite centers in the brain, reducing hunger and food cravings at a neurological level.

That third and fourth mechanism is what makes Ozempic such a powerful weight loss tool. You genuinely feel less hungry, you get full faster, and the constant background noise of food cravings quiets down. Metformin simply does not do this.

Weight Loss: The Numbers Tell the Story

This is where the comparison gets stark.

Ozempic / Semaglutide

In the STEP 1 clinical trial (using semaglutide 2.4 mg, the Wegovy dose):

• Average weight loss: 14.9% of body weight over 68 weeks
• For a 220-pound person, that is roughly 33 pounds
• About 86% of participants lost at least 5% of body weight
• About 32% lost 20% or more

In the Ozempic-specific SUSTAIN trials (using lower doses for diabetes):

• Average weight loss: 8-14 pounds over 30 to 56 weeks at the 1.0 mg dose
• Weight loss was a secondary outcome in these trials, not the primary goal

Metformin

Metformin's weight loss effects are much more modest:

• Average weight loss: 2-5% of body weight over 6 to 12 months
• For a 220-pound person, that is roughly 4-11 pounds
• In the landmark DPP (Diabetes Prevention Program) study, participants on metformin lost an average of 5 pounds over 2.8 years
• Some patients lose no weight at all, while others lose up to 10% over several years
• Weight loss tends to plateau or reverse over longer timeframes

If significant weight loss is your primary goal, the difference is not subtle. Ozempic produces roughly 3 to 5 times more weight loss than metformin.

Use our GLP-1 weight loss calculator to estimate what your results might look like based on your starting weight and medication choice.

Side Effects: What to Expect from Each

Both medications cause gastrointestinal side effects, but the profiles are different.

Metformin Side Effects

• GI issues (most common): Diarrhea, nausea, stomach pain, and gas, especially when starting the medication or increasing the dose. Taking metformin with food and using the extended-release version significantly reduces these effects.
• Vitamin B12 deficiency: Long-term metformin use can reduce B12 absorption. Your provider may check levels periodically and recommend a supplement.
• Lactic acidosis (very rare, very serious): This is an extremely uncommon but potentially life-threatening side effect, primarily a risk for people with kidney disease. Modern monitoring has made this exceedingly rare.
• Metallic taste: Some patients notice a metallic or unpleasant taste, especially at higher doses.

Ozempic Side Effects

• Nausea (most common): Affects 15-20% of patients, usually worst during dose escalation and improving over time. Read our full side effects guide for management strategies.
• Diarrhea and constipation: Both can occur, sometimes alternating.
• Vomiting: Reported in about 5-9% of patients in clinical trials.
• Injection site reactions: Mild redness or irritation at the injection spot, usually temporary.
• Pancreatitis (rare): A small risk of pancreatic inflammation. Seek immediate care for severe, persistent abdominal pain.
• Thyroid tumors (animal studies): Semaglutide caused thyroid C-cell tumors in rodents. This has not been confirmed in humans, but Ozempic carries a boxed warning and is not recommended for people with a personal or family history of medullary thyroid carcinoma.
• Gallbladder issues: Rapid weight loss from any cause increases gallstone risk.

In general, metformin's side effects are well-understood after 30 years of widespread use and are mostly manageable with the extended-release formulation. Ozempic's side effects are more pronounced but tend to improve as your body adjusts.

Cost Comparison: This Is Where Metformin Wins Decisively

There is no sugar-coating this. The cost difference is enormous.

Metformin

• Generic metformin: $4 to $30 per month (available at nearly every pharmacy)
• Extended-release generic: $10 to $40 per month
• With insurance: Often $0 to $10 copay
• Without insurance: Still $4 to $30 at most pharmacies. Walmart, Costco, and many chains include it in their $4 generic programs.

Metformin is one of the cheapest prescription medications in existence. Cost is essentially a non-factor.

Ozempic

• Retail price (brand-name): Approximately $900 to $1,000 per month
• With commercial insurance + savings card: $25 to $150 per month (varies widely)
• Medicare Part D (starting July 2026): Coverage expanding for diabetes, weight loss coverage varies by plan
• Compounded semaglutide (via telehealth): $99 to $349 per month through telehealth providers
• Without insurance and without savings programs: $900+ per month

For patients without insurance or savings program eligibility, this cost difference makes metformin the only realistic option. Check our GLP-1 cost guide for a complete breakdown of pricing options including manufacturer programs and compounding pharmacies.

Who Is Each Medication Best For?

Metformin Is a Strong Choice If:

• You have type 2 diabetes or prediabetes and need first-line treatment
• Cost is a primary concern
• You prefer taking a daily pill over a weekly injection
• You need modest blood sugar improvement without aggressive weight loss
• You have a long-term condition that requires decades of treatment (metformin has 30+ years of safety data)
• You want a medication with a well-established, predictable side effect profile

Ozempic Is a Strong Choice If:

• You need significant weight loss in addition to blood sugar management
• You have tried metformin alone and your A1c or weight goals are not being met
• You prefer a once-weekly injection over daily pills
• You can access insurance coverage, savings programs, or compounded alternatives
• You have cardiovascular risk factors (semaglutide has shown cardiovascular benefits in the SELECT trial)
• Your provider recommends a GLP-1 based on your overall metabolic profile

Neither Is a Good Fit If:

• You have type 1 diabetes (different treatment approach entirely)
• You have a history of pancreatitis (Ozempic) or significant kidney disease (both require careful management)
• You have a personal or family history of medullary thyroid carcinoma (Ozempic is contraindicated)

Can You Take Both Together?

Yes, and many people do. Combining Ozempic and metformin is a well-established treatment strategy for type 2 diabetes. The two medications complement each other because they work through completely different mechanisms:

• Metformin reduces liver glucose production and improves insulin sensitivity
• Ozempic enhances insulin secretion, slows digestion, and suppresses appetite

Together, they address blood sugar from multiple angles. In clinical trials, adding semaglutide to metformin produced greater A1c reduction and more weight loss than either medication alone.

Your provider will monitor for hypoglycemia (low blood sugar), though the risk is relatively low with this combination because neither medication forces insulin release when blood sugar is already normal. They may also adjust metformin dosing if GI side effects become problematic when both medications are on board.

Insurance Coverage: A Tale of Two Worlds

Metformin

Insurance coverage for metformin is essentially universal. Every commercial plan, Medicare Part D, and Medicaid program covers generic metformin. Prior authorization is almost never required. It is as close to universally covered as a medication can be.

Ozempic

Insurance coverage for Ozempic is more complicated:

• Most commercial plans cover Ozempic for type 2 diabetes, though prior authorization and step therapy requirements are common
• For weight loss specifically, coverage depends heavily on your plan. Some cover it, many do not.
• Wegovy (the weight loss formulation of semaglutide) has separate coverage criteria that often require documented BMI thresholds and failed lifestyle interventions
• Medicare Part D is expanding GLP-1 coverage starting July 2026, but specifics vary by plan
• Medicaid coverage varies by state

If you are unsure about your coverage, your provider's office or a GLP-1 clinic can often run a benefits check. Our directory of GLP-1 clinics includes providers across all 50 states who handle insurance navigation daily.

Not sure which path is right for you? Our provider matching quiz takes a couple of minutes and can help point you toward clinics that fit your budget and medication preferences.

:::warning

Do not stop or switch medications without consulting your healthcare provider. Ozempic and Metformin work through different mechanisms, and transitioning between them requires medical supervision to avoid blood sugar fluctuations or other adverse effects.

:::

Other GLP-1 and weight loss medications worth discussing with your provider include Mounjaro and Zepbound (both tirzepatide), Rybelsus (oral semaglutide), and Saxenda (liraglutide). Each has different efficacy, dosing, and cost profiles.

The Bottom Line

Metformin and Ozempic are not really competitors. They are tools with different strengths that serve different situations, and they often work best together.

If you are starting treatment for type 2 diabetes and cost matters (and when does it not?), metformin is a proven, affordable foundation. If you need serious weight loss or your blood sugar is not adequately controlled on metformin alone, adding or switching to Ozempic can produce dramatically better results.

The worst choice is doing nothing because the price tag or the injection seems intimidating. Both of these medications improve health outcomes. The best one for you depends on your goals, your budget, and your body's response. Talk to a provider, get the facts specific to your situation, and make a decision from there.

---

This article is for informational purposes only and is not medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication.

:::warning

The right GLP-1 medication depends on your individual health profile, not just price or average weight loss numbers. Talk to your provider about your medical history, current medications, and treatment goals before making a decision.

:::

Sources

1. Wilding, J.P.H., et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." STEP 1. New England Journal of Medicine, 2021.
2. Diabetes Prevention Program Research Group. "Long-term effects of metformin on diabetes prevention." Diabetes Care, 2012.
3. American Diabetes Association. "Standards of Care in Diabetes." Diabetes Care, 2025.
4. Lincoff, A.M., et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." SELECT Trial. New England Journal of Medicine, 2023.
5. Novo Nordisk. Ozempic (semaglutide) Prescribing Information. FDA.gov, 2024.
6. GLP1 Clinics directory data, March 2026.